Active

TOBUFAR

Switched

BE0464486973

Rechtspersoon Private limited company 1 establishment

Joseph Bensstraat 83A, 1180 Ukkel Groothandel in farmaceutische producten

Active for

27 year, 10 months

Financials

Financial year 2025

Revenue

€ 12.1 million

Profit

Growing

€ 380,924

▲ 21% vs 2024

Debts

Low

€ 1.7 million

▲ 26% vs 2024

TOBUFAR from Ukkel, company number BE0464486973, closed financial year 2025 with a result of € 380,924 after tax. For that financial year TOBUFAR recorded revenue of € 12.1 million and equity of € 5.8 million. Compared with financial year 2024, the result moved from € 315,262 to € 380,924. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 12, 2026.

What happened at TOBUFAR?

What happened at TOBUFAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 380,924 (▲ 21% vs 2024). Source: NBB ↗
  • MEDCOLAB became a director. NBB
  • New establishment in Sint-Genesius-Rode. KBO
  • Start of the company according to the CBE. KBO

In short

From € 208,997 profit in 2021 to € 380,924 profit in 2025.

Paid € 792,744 in corporate taxes since 2021.

Best year ever: 2022, with € 478,554 profit.

On average € 282,800 of value added per employee in 2024.

Original PDFs at the National Bank ↗

A new publication or filing at TOBUFAR? We notify you, reason included.

Follow TOBUFAR

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

William Vandenbulcke 20%
Julien Vandenbulcke 20%
Antoon Vandenbulcke 20%
Charlotte Vandenbulcke 20%
+1
TOBUFAR

Behind TOBUFAR is MEDCOLAB. The shares are held by William Vandenbulcke (20%), Julien Vandenbulcke (20%), Antoon Vandenbulcke (20%), Charlotte Vandenbulcke (20%) and Olivia Vandenbulcke (20%).

See the full network in the app

Directors

According to the 2025 annual accounts

MEDCOLAB

Director · represented by Antoon Vandenbulcke

since 2011

Shareholders

William Vandenbulcke

20%

Julien Vandenbulcke

20%

Antoon Vandenbulcke

20%

Charlotte Vandenbulcke

20%

Olivia Vandenbulcke

20%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Joseph Bensstraat 83A

1180 Ukkel

2.089.060.096

Hallesesteenweg 156

1640 Sint-Genesius-Rode

Active since 2 November 1998

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

JC PHARMA

€ 325,114 gross margin · 2025

Details

Company number
0464.486.973
VAT number
BE 0464.486.973
Registered office
Joseph Bensstraat 83A, 1180 Ukkel
Names & denominations
TOBUFAR
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
30 October 1998
Peppol
Active · Active since 13 Jan 2026
Activities · NACE

Groothandel in farmaceutische producten

Groothandel in farmaceutische en medische artikelen

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What is the enterprise number of TOBUFAR?
The enterprise number of TOBUFAR is BE0464486973.
What is the address of TOBUFAR?
The registered office of TOBUFAR is located at Joseph Bensstraat 83A, 1180 Ukkel.
When was TOBUFAR founded?
TOBUFAR was founded on 30 October 1998.
What is the main activity of TOBUFAR?
The main activity of TOBUFAR is "Groothandel in farmaceutische producten" (NACE code 51460).
Does TOBUFAR have a website?
No website is currently known for TOBUFAR.
How much profit did TOBUFAR make in 2025?
TOBUFAR posted a profit after taxes of € 380,924 in financial year 2025.
What is the revenue of TOBUFAR?
In its most recent annual accounts (2025), TOBUFAR reported revenue of € 12,124,022.
How many employees does TOBUFAR have?
According to the 2025 annual accounts, TOBUFAR has 2.8 full-time equivalents (FTE).
Where can I find the annual accounts of TOBUFAR?
TOBUFAR files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of TOBUFAR?
According to the 2025 annual accounts, the directors of TOBUFAR are: MEDCOLAB.
Who owns TOBUFAR?
Behind TOBUFAR is MEDCOLAB. The shares are held by William Vandenbulcke (20%), Julien Vandenbulcke (20%), Antoon Vandenbulcke (20%), Charlotte Vandenbulcke (20%) and Olivia Vandenbulcke (20%).
Who are the shareholders of TOBUFAR?
According to the 2025 annual accounts, the shareholders of TOBUFAR are: William Vandenbulcke (20%), Julien Vandenbulcke (20%), Antoon Vandenbulcke (20%), Charlotte Vandenbulcke (20%), Olivia Vandenbulcke (20%).